Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET)
Sponsor: Massachusetts General Hospital
Listed as NCT03096314, this PHASE3 trial focuses on Acute Respiratory Distress Syndrome and Critical Illness and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Oct 2019 — Feb 2020 [monthly]
Completed PHASE3
-
Apr 2019 — Oct 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .